Abbott Laboratories Share Price

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:33:43 01/06/2024 am IST 5-day change 1st Jan Change
102.2 USD +0.44% Intraday chart for Abbott Laboratories -1.69% -7.16%
Sales 2024 * 41.72B 3,480B Sales 2025 * 44.73B 3,731B Capitalization 177B 14,763B
Net income 2024 * 5.98B 499B Net income 2025 * 7.17B 598B EV / Sales 2024 * 4.37 x
Net Debt 2024 * 5.47B 456B Net Debt 2025 * 112M 9.35B EV / Sales 2025 * 3.96 x
P/E ratio 2024 *
29.6 x
P/E ratio 2025 *
25.5 x
Employees 1,14,000
Yield 2024 *
2.14%
Yield 2025 *
2.3%
Free-Float 86.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.44%
1 week-1.69%
1 month-3.57%
3 months-13.87%
6 months-2.01%
Current year-7.16%
More quotes
1 week
100.64
Extreme 100.64
103.59
1 month
100.64
Extreme 100.64
106.66
Current year
100.64
Extreme 100.64
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 01/15/01
Director of Finance/CFO 51 01/97/01
Chief Tech/Sci/R&D Officer - 01/90/01
Members of the board TitleAgeSince
Director/Board Member 69 16/17/16
Director/Board Member 63 29/17/29
Director/Board Member 65 09/11/09
More insiders
Date Price Change Volume
31/24/31 102.2 +0.44% 7,915,567
30/24/30 101.7 +1.00% 5,126,729
29/24/29 100.7 -1.20% 4,961,324
28/24/28 102 -1.92% 4,771,127
24/24/24 104 -0.27% 4,455,866

Delayed Quote Nyse, May 01, 2024 at 01:33 am IST

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.2 USD
Average target price
125.4 USD
Spread / Average Target
+22.69%
Consensus